Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson’s Disease
Open accessAbstract
Parkinson's disease (PD) is manifested by progressive motor, autonomic, and cognitive disturbances. Dopamine (DA) synthesizing neurons in the substantia nigra (SN) degenerate, causing a decline in DA level in the striatum that leads to the characteristic movement disorders. A disease-modifying therapy to arrest PD progression remains unattainable with current pharmacotherapies, most of which cause severe side effects and lose their efficacy with time. For this reason, there is a need to seek new therapies supporting the pharmacological treatment of PD. Motor therapy is recommended for pharmacologically treated PD patients as it alleviates the symptoms. Molecular mechanisms behind the beneficial effects of motor therapy are unknown, nor is it known whether such therapy may be neuroprotective in PD patients. Due to obvious limitations, human studies are unlikely to answer these questions; therefore, the use of animal models of PD seems indispensable. Motor therapy in animal models of PD characterized by the loss of dopaminergic neurons has neuroprotective and neuroregenerative effects, and the completeness of neuronal protection may depend on (i) degree of neuronal loss, (ii) duration and intensity of exercise, and (iii) time elapsed between insult and commencing of training. As the physical activity is neuroprotective for dopaminergic neurons, the question arises what is the mechanism of this protective action. A current hypothesis assumes a central role of neurotrophic factors in the neuroprotection of dopaminergic neurons, even though it is still not clear whether increased DA level in the nigrostriatal axis results from neurogenesis of dopaminergic neurons in the SN, recovery of the phenotype of dopaminergic neurons, increased sprouting of the residual dopaminergic axons in the striatum, or generation of local striatal neurons from inhibitory interneurons. In the present review, we discuss studies describing the influence of physical exercise on the PD-like changes manifested in animal models of the disease and focus our interest on the current state of knowledge on the mechanism of neuroprotection induced by physical activity as a supportive therapy in PD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Our study revealed a recovery of the intensity of VMAT2 immunostaining in substantia nigra in exercised MPTP mice.
“Furthermore, our study revealed a recovery of the intensity of vesicular monoamine transporter 2 (VMAT2) immunostaining in SN in exercised MPTP mice, indicative of the increase in the number of dopaminergic neurons [125].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [125]
BDNF upregulation due to exercise was observed in midbrain, substantia nigra, striatum, hippocampus, and cortex.
“BDNF upregulation was observed in midbrain [125], SN [126,128,129], ST [127,129,131,133], hippocampus [133], and cortex [132,133].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [125]
The recovery of VMAT2 immunostaining in substantia nigra in exercised MPTP mice indicates an increase in the number of dopaminergic neurons.
“Furthermore, our study revealed a recovery of the intensity of vesicular monoamine transporter 2 (VMAT2) immunostaining in SN in exercised MPTP mice, indicative of the increase in the number of dopaminergic neurons [125].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [125]
In our study, higher BDNF and GDNF immunostaining intensity was noted in nigrostriatal areas of MPTP-treated mice which started treadmill training before and after intoxication, as compared to control groups both sedentary and exercised.
“In our study, we also noted a higher BDNF and GDNF immunostaining intensity in nigrostriatal areas of MPTP-treated mice which started treadmill training before (preceding training) and after (follow-up training) intoxication, as compared to control groups both sedentary and exercised [125].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · see citing works
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891 · see citing works
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378 · see citing works
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works
Running enhances neurogenesis, learning, and long-term potentiation in mice
van Praag, H., Christie, B. R., Sejnowski, T. J., & Gage, F. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13427 · Cited by 2,904 · see citing works
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470 · see citing works
Exercise builds brain health: key roles of growth factor cascades and inflammation
Cotman, C. W., Berchtold, N. C., & Christie, L.-A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.011 · Cited by 2,268 · see citing works
Exercise enhances learning and hippocampal neurogenesis in aged mice
van Praag, H., Shubert, T., Zhao, C., & Gage, F. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1731-05.2005 · Cited by 2,078 · see citing works
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · see citing works
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works
Brain-derived neurotrophic factor and its clinical Implications
Bathina, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.56342 · Cited by 1,381 · see citing works
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377 · see citing works
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works
Sleiman, S. F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S. S., Holson, E. B., Ratan, R. R., et al. (2016) · eLife · doi:10.7554/elife.15092 · Cited by 810 · see citing works
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810 · see citing works
Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798 · see citing works
Oxidative Stress: Relationship with Exercise and Training
Finaud, J., Lac, G., & Filaire, E. (2006) · Sports Medicine · doi:10.2165/00007256-200636040-00004 · Cited by 771 · see citing works
Beal, M. F. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00780-3 · Cited by 763 · see citing works
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682 · see citing works
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597 · see citing works
Oxidative stress in neurodegenerative diseases.
Chen, X., Guo, C., & Kong, J. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.05.009 · Cited by 572 · see citing works
Prata, C., Zambonin, L., Rizzo, B., Maraldi, T., Angeloni, C., Sega, F. V. D., Fiorentini, D., & Hrelia, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3724545 · Cited by 540 · see citing works
Manoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · see citing works
Inflammation and the Degenerative Diseases of Aging
McGeer, P. L., & McGeer, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 519 · see citing works
Neurotoxin-based models of Parkinson's disease
Bové, J., & Perier, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.057 · Cited by 508 · see citing works
Microglia in degenerative neurological disease
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 500 · see citing works
Axon degeneration in Parkinson's disease
Burke, R. E., & O’Malley, K. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 494 · see citing works
Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain
Siegel, G. J., & Chauhan, N. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00030-8 · Cited by 492 · see citing works
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Fleming, S. M., Salcedo, J. D., Fernagut, P., Rockenstein, E. M., Masliah, E., Levine, M. S., & Chesselet, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3080-04.2004 · Cited by 477 · see citing works
MPTP Mouse Models of Parkinson’s Disease: An Update
Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11023 · Cited by 471 · see citing works
Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer
Thanan, R., Oikawa, S., Hiraku, Y., Ohnishi, S., Ma, N., Pinlaor, S., Yongvanit, P., Kawanishi, S., & Murata, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010193 · Cited by 459 · see citing works
Hirsch, M. A., Toole, T., Maitland, C., & Rider, R. A. (2003) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(03)00046-7 · Cited by 456 · see citing works
Animal models of Parkinson’s disease
Blandini, F., & Armentero, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08491.x · Cited by 428 · see citing works
The ins and outs of the striatum: Role in drug addiction
Yager, L. M., Garcia, A. F., Wunsch, A. M., & Ferguson, S. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.033 · Cited by 421 · see citing works
Mitochondrial membrane permeabilization in neuronal injury
Galluzzi, L., Blomgren, K., & Kroemer, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2665 · Cited by 418 · see citing works
Tillerson, J. L., Caudle, W. M., Reverón, M. E., & Miller, G. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00096-4 · Cited by 399 · see citing works
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Monte, D. A. D., Emson, P. C., & Miller, G. W. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 389 · see citing works
Insulin-like growth factor I is required for vessel remodeling in the adult brain.
Lopez-Lopez, C., LeRoith, D., & Torres-Aleman, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400337101 · Cited by 385 · see citing works
Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works
Levodopa in the treatment of Parkinson's disease: Current controversies
Olanow, C. W., Agid, Y., Mizuno, Y., Albanese, A., Bonucelli, U., Damier, P., De Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., et al. (2004) · Movement Disorders · doi:10.1002/mds.20243 · Cited by 370 · see citing works
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works
Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols
Brown, G. C., & Borutaite, V. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.016 · Cited by 344 · see citing works
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J. H., Haid, S., DICHGANS, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337 · see citing works
Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling
Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00170 · Cited by 330 · see citing works
Fisher, B. E., Petzinger, G. M., Nixon, K., Hogg, E., Bremmer, S., Meshul, C. K., & Jakowec, M. W. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20162 · Cited by 311 · see citing works
Benarroch, E. E. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.10.1326 · Cited by 309 · see citing works
Exercise exerts neuroprotective effects on Parkinson's disease model of rats
Tajiri, N., Yasuhara, T., Shingo, T., Kondo, A., Yuan, W., Kadota, T., Wang, F., Baba, T., Tayra, J. T., Morimoto, T., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2009.10.075 · Cited by 308 · see citing works
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O’Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306 · see citing works
Parain, K., Murer, M. G., Yan, Q., Faucheux, B. A., Agid, Y., Hirsch, É. C., & Raisman‐Vozari, R. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00021 · Cited by 303 · see citing works
Baquet, Z., Bickford, P., & Jones, K. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4601-04.2005 · Cited by 301 · see citing works
Kohutnicka, M., Lewandowska, E., Kurkowska‐Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283 · see citing works
Lau, Y.-S., Patki, G., Das-Panja, K., Le, W.-D., & Ahmad, S. O. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07626.x · Cited by 275 · see citing works
Neuroinflammation and Cerebrovascular Disease in Old Age: A Translational Medicine Perspective
Napoli, M. D., & Shah, I. M. (2011) · Journal of Aging Research · doi:10.4061/2011/857484 · Cited by 262 · see citing works
Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
Dalfó, E., Portero-Otín, M., Ayala, V., Martínez, A., Pamplona, R., & Ferrer, I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000179050.54522.5a · Cited by 261 · see citing works
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
Seet, R. C. S., Lee, J. C., Lim, E. C. H., Tan, J. J. H., Quek, A. M. L., Chong, W.-L., Looi, W. F., Huang, S.-H., Wang, H., Chan, Y., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.026 · Cited by 255 · see citing works
Lu, M., Su, C., Qiao, C., Bian, Y., Ding, J., & Hu, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw047 · Cited by 252 · see citing works
Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240 · cited 1× · see citing works
“For instance, it may inhibit the activity of glycogen synthase kinase 3 (GSK3), which is a major regulator of the balance between the proand anti-inflammatory mediators in immune cells, including microglia (137).”
BackgroundPrice, D. A., Martinez, A. A., Seillier, A., Koek, W., Acosta, Y. P. V., Fernández, E., Strong, R., Lutz, B., Marsicano, G., Roberts, J. L., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06764.x · Cited by 231 · see citing works
Cruise, K. E., Bucks, R. S., Loftus, A. M., Newton, R. U., Pegoraro, R., & Thomas, M. G. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01338.x · Cited by 229 · see citing works
The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism
Rozas, G., López-Martín, M. E., Guerra, M. J., & Labandeira-García, J. L. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00078-8 · Cited by 225 · see citing works
Resistance Training and Gait Function in Patients with Parkinson’s Disease
Scandalis, T. A., Bosak, A. M., Berliner, J. C., Helman, L. L., & Wells, M. R. (2001) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-200101000-00011 · Cited by 222 · see citing works
Erickson, G. M., Gignac, P. M., Steppan, S. J., Lappin, A. K., Vliet, K. A., Brueggen, J. D., Inouye, B. D., Kledzik, D., & Webb, G. J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031781 · Cited by 218 · see citing works
Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
Brichta, L., & Greengard, P. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00152 · Cited by 214 · see citing works
Van der Borght, K., Kóbor‐Nyakas, D. É., Klauke, K., Eggen, B. J. L., Nyakas, C., Van der Zee, E. A., & Meerlo, P. (2009) · Hippocampus · doi:10.1002/hipo.20545 · Cited by 210 · see citing works
Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆
Smith, A. D., & Zigmond, M. J. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.017 · Cited by 209 · see citing works
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease
Zhang, Q.-S., Heng, Y., Mou, Z., Huang, J.-Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.49 · Cited by 208 · see citing works
Chauhan, N. B., Siegel, G. J., & Lee, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00115-6 · Cited by 207 · see citing works
Wu, S.-Y., Wang, T.-F., Yu, L., Jen, C. J., Chuang, J.-I., Wu, F.-S., Wu, C.-W., & Kuo, Y.-M. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.006 · Cited by 206 · see citing works
Tillerson, J. L., Caudle, W. M., Reveron, M. E., & Miller, G. W. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8021 · Cited by 192 · see citing works
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Lee, E.-R., Kim, J.-Y., Kang, Y.-J., Ahn, J.-Y., Kim, J., Kim, B., Choi, H.-Y., Jeong, M.-Y., & Cho, S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.06.006 · Cited by 190 · see citing works
Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
Neal, M. P., & Richardson, J. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.004 · Cited by 185 · see citing works
Reuter, I., Mehnert, S., Leone, P., Kaps, M., Oechsner, M., & Engelhardt, M. (2011) · Journal of Aging Research · doi:10.4061/2011/232473 · Cited by 182 · see citing works
Wu, C., Chen, Y., Yu, L., Chen, H., Jen, C. J., Huang, A., Tsai, H., Chang, Y., & Kuo, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04987.x · Cited by 175 · see citing works
Toy, W. A., Petzinger, G. M., Leyshon, B. J., Akopian, G. K., Walsh, J. P., Hoffman, M., Vuckovic, M. G., & Jakowec, M. W. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.017 · Cited by 173 · see citing works
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171 · see citing works
Cugusi, L., Solla, P., Serpe, R., Carzedda, T., Piras, L., Oggianu, M., Gabba, S., Blasio, A. D., Bergamin, M., Cannas, A., et al. (2015) · Neurorehabilitation · doi:10.3233/nre-151257 · Cited by 166 · see citing works
Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease
Pisani, A., Centonze, D., Bernardi, G., & Calabresi, P. (2005) · Movement Disorders · doi:10.1002/mds.20394 · Cited by 161 · see citing works
Petzinger, G. M., Holschneider, D. P., Fisher, B. E., McEwen, S. C., Kintz, N. M., Halliday, M. R., Toy, W., Walsh, J. W., Beeler, J. A., & Jakowec, M. W. (2015) · Brain Plasticity · doi:10.3233/bpl-150021 · Cited by 149 · see citing works
Sundström, E., Fredriksson, A., & Archer, T. (1990) · Brain Research · doi:10.1016/0006-8993(90)91656-2 · Cited by 145 · see citing works
Tuon, T., Valvassori, S. S., Lopes-Borges, J., Luciano, T. F., Tromm, C. B., da Silva, L. A., Quevedo, J., de Souza, C. T., Lira, F. S., & Pinho, R. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.063 · Cited by 139 · see citing works
Pothakos, K., Kurz, M. J., & Lau, Y.-S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-6 · Cited by 134 · see citing works
The best medicine? The influence of physical activity and inactivity on Parkinson's disease
LaHue, S. C., Comella, C. L., & Tanner, C. M. (2016) · Movement Disorders · doi:10.1002/mds.26728 · Cited by 133 · see citing works
Ferritin as an important player in neurodegeneration
Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., & Gałązka-Friedman, J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.016 · Cited by 130 · see citing works
Sung, Y.-H., Kim, S.-C., Hong, H.-P., Park, C.-Y., Shin, M.-S., Kim, C., Seo, J.-H., Kim, D., Kim, D.-J., & Cho, H. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.003 · Cited by 129 · see citing works
Repairing the parkinsonian brain with neurotrophic factors
Aron, L., & Klein, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.11.001 · Cited by 126 · see citing works
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease
Haggerty, T., Credle, J. J., Rodriguez, O. C., Wills, J., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07660.x · Cited by 126 · see citing works
Monteiro, E. P., Franzoni, L. T., Arcila, D. M. C., Fagundes, A. D. O., de Carvalho, A. R., Oliveira, H. B., Pantoja, P. D., Schuch, F. B., Rieder, C. R. D. M., Martinez, F. G., et al. (2016) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12652 · Cited by 123 · see citing works
GDNF–Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease
Kramer, E. R., & Liss, B. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.11.006 · Cited by 121 · see citing works
Chung, Y. C., Baek, J. Y., Kim, S. R., Ko, H. W., Bok, E., Shin, W.-H., Won, S.-Y., & Jin, B. K. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.159 · Cited by 121 · see citing works
Zhu, G., Li, J., He, L., Wang, X., & Hong, X. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13061 · Cited by 118 · see citing works
Wang, M.-J., Huang, H., Chen, W.-F., Chang, H., & Kuo, J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-99 · Cited by 116 · see citing works
GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
Green, H. F., & Nolan, Y. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.003 · Cited by 115 · see citing works
Exercise protects against MPTP-induced neurotoxicity in mice
Gerecke, K. M., Jiao, Y., Pani, A. K., Pagala, V., & Smeyne, R. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.053 · Cited by 114 · see citing works
Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease
Chen, Y., Zhang, Y., Li, L., & Hölscher, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.029 · Cited by 111 · see citing works
Mohammadi, A., Amooeian, V. G., & Rashidi, E. (2018) · Current Gene Therapy · doi:10.2174/1566523218666180302163029 · Cited by 111 · see citing works
Lofrumento, D. D., Saponaro, C., Cianciulli, A., Nuccio, F. D., Mitolo, V., Nicolardi, G., & Panaro, M. A. (2010) · NeuroImmunoModulation · doi:10.1159/000320027 · Cited by 109 · see citing works
Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108 · see citing works
Monteiro-Júnior, R. S., Cevada, T., Oliveira, B. R. R., Lattari, E., Portugal, E. M. M., de Carvalho, A. O., & Deslandes, A. C. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.07.011 · Cited by 104 · see citing works
The effects of treadmill or overground walking training program on gait in Parkinson's disease
Bello, O., Sánchez, J. A., López-Alonso, V., Márquez, G., Morenilla, L., Castro, X., García, M. A. G., Santos‐García, D., & Fernández‐del‐Olmo, M. (2013) · Gait & Posture · doi:10.1016/j.gaitpost.2013.02.005 · Cited by 104 · see citing works
Effects of 24 wk of Treadmill Training on Gait Performance in Parkinson’s Disease
Nadeau, A., Pourcher, E., & Corbeil, P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000144 · Cited by 102 · see citing works
Goes, A. T. R., Souza, L. C., Filho, C. B., Fabbro, L. D., de Gomes, M. G., Boeira, S. P., & Jessé, C. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.042 · Cited by 98 · see citing works
Jang, Y., Koo, J., Kwon, I., Kang, E., Um, H.-S., Soya, H., Lee, Y., & Cho, J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.10.029 · Cited by 97 · see citing works
Manning-Bog, A., Caudle, W. M., Perez, X. A., Reaney, S. H., Paletzki, R. F., Isla, M. Z., Chou, V., McCormack, A. L., Miller, G. W., Langston, J. W., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.014 · Cited by 96 · see citing works
Tsou, Y.-H., Shih, C.-T., Ching, C., Huang, J.-Y., Jen, C. J., Yu, L., Kuo, Y., Wu, F., & Chuang, J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.021 · Cited by 95 · see citing works
Neuroprotective Effects of Exercise Treatments after Injury: The Dual Role of Neurotrophic Factors
Cobianchi, S., Arbat-Plana, A., Lopez-Alvarez, V. M., & Navarro, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160330105132 · Cited by 94 · see citing works
Exercise as a Positive Modulator of Brain Function
Alkadhi, K. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0516-4 · Cited by 90 · see citing works
Kim, S. T., Son, H. J., Choi, J. H., Ji, I. J., & Hwang, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.103 · Cited by 89 · see citing works
Rodrigues, R. W. P., Gomide, V. C., & Chadi, G. (2001) · International Journal of Neuroscience · doi:10.3109/00207450108986528 · Cited by 88 · see citing works
Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis
Yasuhara, T., Hara, K., Maki, M., Matsukawa, N., Fujino, H., Date, I., & Borlongan, C. V. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.045 · Cited by 87 · see citing works
MPTP-induced behavioural and biochemical deficits: A parametric analysis
Fredriksson, A., & Archer, T. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260967 · Cited by 85 · see citing works
Mitochondrial Dysfunction in Neurodegenerative Diseases
Schapira, A. H. V. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9855-x · Cited by 84 · see citing works
Aguiar, A. S., Duzzioni, M., Remor, A. P., Tristão, F. S. M., MATHEUS, F. C., Raisman‐Vozari, R., Latini, A., & Prediger, R. D. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1709-8 · Cited by 82 · see citing works
Hernández, E., Starling, A. J., Cepeda, C., & Levine, M. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03344.x · Cited by 82 · see citing works
l ‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T. T., Pillai, E., Fisone, G., Raisman‐Vozari, R., & Bel, E. A. D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 76 · see citing works
The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.
Maixner, D. W., & Weng, H.-R. (2013) · Journal of Pharmaceutics & Pharmacology · doi:10.13188/2327-204x.1000001 · Cited by 75 · see citing works
The MPTP-treated mouse as a model of Parkinsonism: How good is it?
Heikkila, R. E., & Sonsalla, P. K. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90256-q · Cited by 74 · see citing works
Tenenbaum, L., & Humbert‐Claude, M. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00029 · Cited by 72 · see citing works
Yang, J.-W., Ru, J., Ma, W., Gao, Y., Liang, Z., Liu, J., Guo, J.-H., & Li, L.-Y. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.08.005 · Cited by 70 · see citing works
Al-Jarrah, M. D., Pothakos, K., Novikova, L., Smirnova, I. V., Kurz, M. J., Stehno‐Bittel, L., & Lau, Y.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.038 · Cited by 69 · see citing works
Exercise improves efficacy of levodopa in patients with Parkinson's disease
Muhlack, S., Welnic, J., Woitalla, D., & Müller, T. H. (2007) · Movement Disorders · doi:10.1002/mds.21346 · Cited by 68 · see citing works
Real, C. C., Garcia, P. C., & Britto, L. R. G. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0955-4 · Cited by 66 · see citing works
Inflammation and neurodegeneration: chronicity matters
Walker, K. A. (2018) · Aging · doi:10.18632/aging.101704 · Cited by 66 · see citing works
Yi, S. S., Hwang, I. K., Yoo, K., Park, O. K., Yu, J., Yan, B., Kim, I. Y., Kim, Y. N., Pai, T.-K., Song, W. J., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9870-y · Cited by 62 · see citing works
Ambrogini, P., Lattanzi, D., Ciuffoli, S., Betti, M., Fanelli, M., & Cuppini, R. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.023 · Cited by 61 · see citing works
Koo, J., & Cho, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9770-5 · Cited by 61 · see citing works
Shin, M., Jeong, H.-Y., An, D.-I., Lee, H.-Y., & Sung, Y.-H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.015 · Cited by 60 · see citing works
da Costa, R. O., Gadelha-Filho, C. V. J., da Costa, A. E. M., Feitosa, M. L., de Araújo, D. P., de Lucena, J. D., de Aquino, P. E. A., Lima, F. A. V., Neves, K. R. T., & Viana, G. S. D. B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2138169 · Cited by 59 · see citing works
Jang, Y., Kwon, I., Song, W., Cosío-Lima, L., & Lee, Y. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.015 · Cited by 58 · see citing works
Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
Liu, J., Huang, D., Xu, J., Tong, J., Wang, Z., Huang, L., Yang, Y., Bai, X., Wang, P., Suo, H., et al. (2015) · Scientific Reports · doi:10.1038/srep15720 · Cited by 57 · see citing works
Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants
González‐Polo, R. A., Soler, G., Rodrı́guez-Martı́n, A., Morán, J. M., & Fuentes, J. M. (2004) · Cell Biology International · doi:10.1016/j.cellbi.2004.03.005 · Cited by 57 · see citing works
Sconce, M. D., Churchill, M. J., Greene, R. E., & Meshul, C. K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.069 · Cited by 56 · see citing works
Ebersbach, G., Ebersbach, A., Gandor, F., Wegner, B., Wissel, J., & Kupsch, A. R. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.10.020 · Cited by 54 · see citing works
Koo, J., Cho, J., & Lee, U.-B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.01.001 · Cited by 54 · see citing works
Exercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice
Gerecke, K. M., Jiao, Y., Pagala, V., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043250 · Cited by 53 · see citing works
Schwenkgrub, J., Zaremba, M., Joniec‐Maciejak, I., Cudna, A., Mirowska-Guzel, D. M., & Kurkowska‐Jastrzębska, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182019 · Cited by 53 · see citing works
Relationship between increase in astrocytic GLT-1 glutamate transport and late-LTP
Pita-Almenar, J. D., Zou, S., Colbert, C. M., & Eskin, A. (2012) · Learning & Memory · doi:10.1101/lm.023259.111 · Cited by 52 · see citing works
The Effect of Physical Activity in Parkinson’s Disease: A Mini-Review
Fayyaz, M., Jaffery, S. S., Anwar, F., Zil‐E‐Ali, A., & Anjum, I. (2018) · Cureus · doi:10.7759/cureus.2995 · Cited by 52 · see citing works
Aerobic Exercise to Improve Executive Function in Parkinson Disease
Tabak, R. G., Aquije, G., & Fisher, B. E. (2013) · Neurology Report · doi:10.1097/npt.0b013e31829219bc · Cited by 49 · see citing works
Role of Neurotrophic Factors in Parkinson's Disease
Tomé, D., Fonseca, C. P., Campos, F., & Baltazar, G. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161208120422 · Cited by 49 · see citing works
Hsueh, S., Chen, K., Lai, J.-H., Wu, C.-C., Yu, Y.-W., Luo, Y., Hsieh, T.-H., & Chiang, Y. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020508 · Cited by 49 · see citing works
Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats
Sharma, S., & Deshmukh, R. R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.008 · Cited by 48 · see citing works
Sharma, S., Kumar, K., Deshmukh, R. R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.038 · Cited by 47 · see citing works
Chuang, C., Chang, J., Cheng, F., Liu, K., Su, H., & Liu, C. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.003 · Cited by 44 · see citing works
Sawada, H., Hishida, R., Hirata, Y., Ono, K., Suzuki, H., Muramatsu, S., Nakano, I., Nagatsu, T., & Sawada, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21241 · Cited by 41 · see citing works
Klein, C., Rasińska, J., Empl, L., Sparenberg, M., Poshtiban, A., Hain, E. G., Iggena, D., Rivalan, M., Winter, Y., & Steiner, B. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.02.040 · Cited by 41 · see citing works
Koo, J., & Cho, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9779-9 · Cited by 41 · see citing works
Ahmad, S. O., Park, J., Stenho-Bittel, L., & Lau, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.065 · Cited by 40 · see citing works
Kintz, N. M., Petzinger, G. M., Akopian, G. K., Ptasnik, S., Williams, C., Jakowec, M. W., & Walsh, J. P. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23260 · Cited by 39 · see citing works
Can exercise improve language and cognition in Parkinson's disease? A case report
Nocera, J. R., Altmann, L. J. P., Sapienza, C. M., Okun, M. S., & Hass, C. J. (2010) · Neurocase · doi:10.1080/13554790903559663 · Cited by 39 · see citing works
Palasz, E., Niewiadomski, W., Gasiorowska, A., Mietelska-Porowska, A., & Niewiadomska, G. (2019) · Neural Plasticity · doi:10.1155/2019/8215017 · Cited by 39 · see citing works
Self-citationSaavedra, A., Baltazar, G., & Duarte, E. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.019 · Cited by 37 · see citing works
Chen, Y.-H., Kuo, T., Kao, J., Huang, E. Y., Hsieh, T.-H., Chou, Y., & Hoffer, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22462-y · Cited by 37 · see citing works
Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment
Korecka, J., Eggers, R., Swaab, D., Bossers, K., & Verhaagen, J. (2013) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-110222 · Cited by 35 · see citing works
ZHAO, L., HE, L. X., HUANG, S. N., Gong, L., LI, L., LV, Y. Y., & Qian, Z. (2014) · Physiological Research · doi:10.33549/physiolres.932743 · Cited by 35 · see citing works
Yue, P., Gao, L., Wang, X., Ding, X., & Teng, J. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2184-1 · Cited by 35 · see citing works
Bazzu, G., Calia, G., Puggioni, G., Spissu, Y., Rocchitta, G., Debetto, P., Grigoletto, J., Zusso, M., Migheli, R., Serra, P. A., et al. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791556177 · Cited by 34 · see citing works
Dimatelis, J. J., Hendricks, S., Hsieh, J. H., Vlok, N. M., Bugarith, K., Daniels, W. M. U., & Russell, V. A. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.066720 · Cited by 33 · see citing works
Al-Jarrah, M. D., & Jamous, M. (2011) · Neurorehabilitation · doi:10.3233/nre-2011-0664 · Cited by 33 · see citing works
Lindgren, N., Leak, R. K., Carlson, K. M., Smith, A. D., & Zigmond, M. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21641 · Cited by 32 · see citing works
Al-Jarrah, M. D., Obaidat, H., Bataineh, Z., Walton, L. M., & Al-Khateeb, A. (2013) · Neurorehabilitation · doi:10.3233/nre-130831 · Cited by 29 · see citing works
Patki, G., & Lau, Y. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.036 · Cited by 29 · see citing works
Schamne, M. G., Mack, J. M., Moretti, M., MATHEUS, F. C., Walz, R., Lanfumey, L., & Prediger, R. D. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9912-4 · Cited by 29 · see citing works
Wi, S., Lee, J. W., Kim, M., Park, C., & Cho, S. (2018) · Cell Transplantation · doi:10.1177/0963689717742662 · Cited by 27 · see citing works
Bian, M., Li, L., Yu, M., Fei, J., & Huang, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.030 · Cited by 26 · see citing works
Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice
Liu, J., Wang, M., Gu, P., Ma, Q., Wang, Y.-Y., Geng, Y., Yuan, Z.-Y., Cui, D., Zhang, Z., Ma, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.043 · Cited by 23 · see citing works
García‐Martínez, J. M., Pérez‐Navarro, E., Gavaldà, N., & Alberch, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20713 · Cited by 23 · see citing works
Koziorowski, D., Hoffman‐Zacharska, D., Sławek, J. W., Jamrozik, Z., Janik, P., Potulska‐Chromik, A., Roszmann, A., Tataj, R., Bal, J., & Friedman, A. (2013) · Neurologia i Neurochirurgia Polska · doi:10.5114/ninp.2013.36756 · Cited by 22 · see citing works
Yang, J., Ma, W., Luo, T., Wang, D., Lu, J., Li, X.-T., Wang, T.-T., Cheng, J., Ru, J., Gao, Y., et al. (2016) · Growth Factors · doi:10.3109/08977194.2016.1157791 · Cited by 22 · see citing works
Elokda, A. S., DiFrancisco‐Donoghue, J., Lamberg, E. M., & Werner, W. G. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5584-6 · Cited by 21 · see citing works
Zhang, L., Feng, Y., Ji, W., Liu, J., & Liu, K. (2017) · Behavioural Neurology · doi:10.1155/2017/6137071 · Cited by 20 · see citing works
Chalimoniuk, M., Jagsz, S., Sadowska‐Krępa, E., Chrapusta, S. J., Kłapcińska, B., & Langfort, J. (2015) · PubMed · Cited by 19 · see citing works
Zhou, Y., Zhu, J., Lv, Y., Song, C., Ding, J., Xiao, M., Lu, M., & Hu, G. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1005-0 · Cited by 18 · see citing works
Lau, Y., Fung, Y. K., Trobough, K. L., Cashman, J., & Wilson, J. A. (1991) · PubMed · Cited by 15 · see citing works
Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings
Archer, T., & Kostrzewa, R. M. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_409 · Cited by 11 · see citing works
Salama, M., El-Dakroory, S., El‐Tantawy, D., Ghanem, A. A., Abdel-ghaffar, H. A., Elhusseiny, M., & El-Hak, S. G. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.05.005 · Cited by 10 · see citing works
Cecchetti, L., Lettieri, G., Handjaras, G., Leo, A., Ricciardi, E., Pietrini, P., & Pellegrini, S. (2019) · Journal of Neural Transplantation and Plasticity · doi:10.1155/2019/6874805 · Cited by 10 · see citing works
TracMouse: A computer aided movement analysis script for the mouse inverted horizontal grid test
Niewiadomski, W., Pałasz, E., Skupińska, M., Żyliński, M., Steczkowska, M., Gąsiorowska, A., Niewiadomska, G., & Riedel, G. (2016) · Scientific Reports · doi:10.1038/srep39331 · Cited by 8 · see citing works
Self-citationEffects of Voluntary Exercise on Motor Function in Parkinson's disease Model of Rats
Rafie, F., Shabazi, M., Sheikh, M., Naghdi, N., & Sheibani, V. (2017) · Annals of Applied Sport Science · doi:10.18869/acadpub.aassjournal.5.2.81 · Cited by 6 · see citing works
Anti-inflammatory microglial cell function in the light of the latest scientific research
Łabuzek, K., Skrudlik, E., Gabryel, B., & Okopień, B. (2015) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/32608 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 182 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works
Self-citationTreatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
Church, F. (2021) · Biomolecules · doi:10.3390/biom11040612 · Cited by 303 · see citing works
Gąsiorowska, A., Wydrych, M., Drapich, P., Zadrożny, M., Steczkowska, M., Niewiadomski, W., & Niewiadomska, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654931 · Cited by 192 · see citing works
Self-citationExercise as medicine in Parkinson’s disease
Langeskov‐Christensen, M., Franzén, E., Hvid, L. G., & Dalgas, U. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332974 · Cited by 96 · see citing works
Cristini, J., Weiss, M., Heras, B. D. L., Medina‐Rincón, A., Dagher, A., Postuma, R. B., Huber, R., Doyon, J., Rosa‐Neto, P., Carrier, J., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101384 · Cited by 90 · see citing works
Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases
Bonanni, R., Cariati, I., Tarantino, U., D’Arcangelo, G., & Tancredi, V. (2022) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk7020038 · Cited by 94 · see citing works
Exercise as a Positive Modulator of Brain Function
Alkadhi, K. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0516-4 · Cited by 90 · see citing works
The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
Razali, K., Othman, N., Nasir, M. H. M., Doolaanea, A. A., Kumar, J., Ibrahim, W. N., Ibrahim, N. M., & Mohamed, W. M. Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.655550 · Cited by 85 · see citing works
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 74 · see citing works
Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases
Marques‐Aleixo, I., Beleza, J., Sampaio, A., Stevanović, J., Coxito, P. M., Gonçalves, I. O., Ascensão, A. A. M. R., & Magalhães, J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8075 · Cited by 62 · see citing works
Lifestyle Interventions for the Prevention of Parkinson Disease
Daalen, J. M. J., Schootemeijer, S., Richard, E., Darweesh, S. K. L., & Bloem, B. R. (2022) · Neurology · doi:10.1212/wnl.0000000000200787 · Cited by 61 · see citing works
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 62 · see citing works
Li, F., Geng, X., Huber, C., Stone, C., & Ding, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00186 · Cited by 50 · see citing works
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease
Marchetti, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101664 · Cited by 49 · see citing works
Humińska‐Lisowska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111602 · Cited by 52 · see citing works
Reuland, C. J., & Church, F. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109602 · Cited by 40 · see citing works
Wang, L., Ma, J., Wu, W., Fang, Y., Liu, F., Yang, Q., Hu, X., Gu, X., He, Z., Sun, D., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120578 · Cited by 38 · see citing works
New horizons in Parkinson’s disease in older populations
Chhetri, J. K., Mei, S., Wang, C., & Chan, P. (2023) · Age and Ageing · doi:10.1093/ageing/afad186 · Cited by 37 · see citing works
Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00361-1 · Cited by 36 · see citing works
Neurotrophic factor-based pharmacological approaches in neurological disorders
Castelli, V., Alfonsetti, M., & d’Angelo, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.358619 · Cited by 30 · see citing works
The effects of treadmill exercise in animal models of Parkinson’s disease: A systematic review
Ferreira, A. F. F., Binda, K. H., & Real, C. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.019 · Cited by 29 · see citing works
Association of Physical Activity and Parkinson Disease in Women
Portugal, B., Artaud, F., Degaey, I., Roze, E. F., Fournier, A., Severi, G., Canonico, M., Proust‐Lima, C., & Elbaz, A. (2023) · Neurology · doi:10.1212/wnl.0000000000207424 · Cited by 29 · see citing works
Compensatory cognition in neurological diseases and aging: A review of animal and human studies
Kanishka, K., & Jha, S. K. (2022) · Aging Brain · doi:10.1016/j.nbas.2022.100061 · Cited by 30 · see citing works
Rafie, F., Rajizadeh, M. A., Shahbazi, M., Pourranjbar, M., Nekouei, A. H., Sheibani, V., & Peterson, D. S. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102357 · Cited by 26 · see citing works
Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review
Mitchell, A. K., Bliss, R. R., & Church, F. (2024) · Biomolecules · doi:10.3390/biom14101241 · Cited by 32 · see citing works
Seo, J. H., Kang, S., Kim, K., Wi, S., Lee, J. W., & Cho, S. (2020) · Antioxidants · doi:10.3390/antiox9100928 · Cited by 26 · see citing works
Dhiman, S., Mannan, A., Taneja, A., Mohan, M., & Singh, T. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122537 · Cited by 25 · see citing works
Consorti, A., Marco, I. D., & Sansevero, G. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.710303 · Cited by 25 · see citing works
Ishaq, S., Shah, I. A., Lee, S., & Wu, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1464168 · Cited by 22 · see citing works
da Costa, R. O., Gadelha-Filho, C. V. J., de Aquino, P. É. A., Lima, L. A. R., de Lucena, J. D., Ribeiro, W. L. C., Lima, F. A. V., Neves, K. R. T., & Viana, G. S. D. B. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03728-4 · Cited by 22 · see citing works
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 18 · see citing works
Hall, M.-F. E., & Church, F. (2020) · Brain Sciences · doi:10.3390/brainsci10090612 · Cited by 17 · see citing works
Intervention strategies for Parkinson’s disease: the role of exercise and mitochondria
Xu, G., Ma, C., & Yang, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1519672 · Cited by 17 · see citing works
Wei, J., Liu, L., Song, X., Lin, B., Cui, J., Luo, L., Liu, Y., Li, S., Li, X., So, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112240 · Cited by 17 · see citing works
Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease
de Vries, N. M., Darweesh, S. K. L., & Bloem, B. R. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3744 · Cited by 15 · see citing works
Cammisuli, D. M., Bonuccelli, U., Daniele, S., Martini, C., Fusi, J., & Franzoni, F. (2020) · Antioxidants · doi:10.3390/antiox9050380 · Cited by 15 · see citing works
The roles, mechanism, and mobilization strategy of endogenous neural stem cells in brain injury
Liu, H., Wei, T., Huang, Q., Liu, W., Yang, Y., Jin, Y., Wu, D., Yuan, K., & Zhang, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.924262 · Cited by 14 · see citing works
Effects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14 · see citing works
Enriched environment as a nonpharmacological neuroprotective strategy
Vaquero-Rodríguez, A., Ortuzar, N., Lafuente, J. V., & Bengoetxea, H. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231171915 · Cited by 14 · see citing works
Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
Feigl, B., Lewis, S. J. G., & Rawashdeh, O. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12073-7 · Cited by 15 · see citing works
Kasanga, E. A., Soto, I., Centner, A., McManus, R., Shifflet, M. K., Navarrete, W., Han, Y., Lisk, J. P., Ehrhardt, T., Wheeler, K., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114875 · Cited by 14 · see citing works
Schootemeijer, S., de Vries, N. M., Darweesh, S. K. L., Ascherio, A., Schwarzschild, M. A., Macklin, E. A., & Bloem, B. R. (2025) · Neurology Report · doi:10.1097/npt.0000000000000507 · Cited by 14 · see citing works
Pałasz, E., Gąsiorowska, A., Drapich, P., Niewiadomski, W., & Niewiadomska, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031146 · Cited by 12 · see citing works
Self-citationTherapeutic Mechanisms of Exercise in Parkinson’s Disease
Wilson, A. C., Pountney, D. L., & Khoo, T. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104860 · Cited by 13 · see citing works
Fan, X., Yuan, Y., Bai, Y., Chen, C., Wang, J., Wang, T., Yang, Y., & Chen, K.-C. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08244-1 · Cited by 11 · see citing works
Considerations on How to Prevent Parkinson’s Disease Through Exercise
Oosterhof, T. H., Darweesh, S. K. L., Bloem, B. R., & de Vries, N. M. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240091 · Cited by 11 · see citing works
Kang, H., Wang, X., Sun, Y., Li, S., Sun, X., Li, F., Hou, C., Lam, S., Zhang, W., & Zheng, Y. (2024) · Bioengineering · doi:10.3390/bioengineering11090889 · Cited by 9 · see citing works
Li, H., Gao, M., Chen, Z., Zhou, Z., Li, W., Zhang, X., Jiang, X., Luo, L., Li, F. R., Wang, G., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7790 · Cited by 9 · see citing works
Feliciano, J. S., Rodrigues, S. M. A., Lana, R. D. C., & Polese, J. C. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04701-1 · Cited by 9 · see citing works
Bridging the Gap: The Neuro-immune Axis as a Key Player in Neurodegenerative Disorders
Liu, T., Wu, H., & Wei, J. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01439-8 · Cited by 9 · see citing works
Blanco, E. C., Pascual‐Diaz, S., Carreño, M., Muñoz‐Moreno, E., Pariente, J. C., Boget, T., Manzanares, I., Donaire, A., Centeno, M., Graus, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89010-z · Cited by 8 · see citing works
Chen, Y., Liaw, Y.-C., Nfor, O. N., Hsiao, C.-H., Zhong, J.-H., Wu, S., & Liaw, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1235840 · Cited by 9 · see citing works
Zhang, J.-W., Xie, D., Jiao, D.-L., Zhou, S., Liu, S.-M., Ju, Z.-Y., Hu, L., Qi, L., Yao, C., & Zhao, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32688 · Cited by 14 · see citing works
Wang, B., Li, N., Wang, Y., Tian, X., Lin, J., Zhang, X., Xu, H., Sun, Y., & Zhao, R. (2025) · Biology · doi:10.3390/biology14080955 · Cited by 8 · see citing works
Franco, B., Mota, D. S., Daubian‐Nosé, P., Rodrigues, N. D. A., Simino, L. A. D. P., de Fante, T., Bezerra, R. M. N., Manchado-Gobatto, F. D. B., Manconi, M., Torsoni, A. S., et al. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24968 · Cited by 7 · see citing works
Caminiti, S. P., Gallo, S., Menegon, F., Naldi, A., Comi, C., & Tondo, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230616121213 · Cited by 7 · see citing works
Animal models of action control and cognitive dysfunction in Parkinson's disease
Balleine, B. W. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.006 · Cited by 5 · see citing works
The global rise in Parkinson's disease: a critical analysis of causes and future directions
León-Rojas, J. E. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1606732 · Cited by 5 · see citing works
Vaquero-Rodríguez, A., Razquin, J., Zubelzu, M., Bidgood, R., Bengoetxea, H., Miguélez, C., Morera‐Herreras, T., Ruíz-Ortega, J. Á., Lafuente, J. V., & Ortuzar, N. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.010 · Cited by 5 · see citing works
de Abreu, F. M. C., de Oliveira, D. A., Ferrari, S. S. D. A. R., Silva, K. H. C. V. E., Titze‐de‐Almeida, R., & Titze-de-Almeida, S. S. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01409-9 · Cited by 5 · see citing works
Zhang, Y., Zhou, L., Lian, H., Zhang, Y., Tong, S., & Wang, Z. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102016 · Cited by 5 · see citing works
Baldauf, L., Feja, M., Stanojlović, M., Strowig, T., Visscher, C., Schaeffer, E., Berg, D., Hankel, J., & Richter, F. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01200-y · Cited by 3 · see citing works
Duppen, C., Sachdeva, N., Wrona, H., Dayan, E., Browner, N., & Lewek, M. D. (2024) · Experimental Brain Research · doi:10.1007/s00221-024-06933-5 · Cited by 3 · see citing works
Reduced penetrance of Parkinson’s disease models
Morais, V. A., & Vos, M. H. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2138 · Cited by 3 · see citing works
Medical treatment of the motor features of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C. L., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00006-8 · Cited by 3 · see citing works
Hasani, M., Sidiropoulou, I., Christakou, Α., Marazioti, A., Konitsiotis, S., & Lyros, E. (2026) · NeuroSci · doi:10.3390/neurosci7020042 · Cited by 2 · see citing works
Chauhan, P., Pandey, P., Khan, F., & Maqsood, R. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303249690231006114308 · Cited by 2 · see citing works
Olivares-García, R., López‐Cruz, L., Carratalá‐Ros, C., Matas-Navarro, P., Salamone, J. D., & Correa, M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110197 · Cited by 2 · see citing works
Unraveling the core: hub genes bridging familial and sporadic Parkinson’s disease
Singh, S., Chauhan, G., Moharana, B., & Verma, S. (2026) · Journal of Neurology · doi:10.1007/s00415-025-13429-x · Cited by 1 · see citing works
Oosterhof, T. H., Mitchell, E., Ascherio, A., Aslibekyan, S. W., Azoidou, V., Beasley, K., Ben‐Shlomo, Y., Bunnik, E. M., Carroll, C., Chahine, L., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01463-z · Cited by 1 · see citing works
Nervenzellen retten oder ersetzen – welche Strategie ist erfolgreicher?
Klimaschewski, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-662-63392-2_3 · Cited by 1 · see citing works
Rasińska, J., Klein, C., Stahn, L., Maidhof, F., Pfeffer, A., Schreyer, S., Gossen, M., Kurtz, A., Steiner, B., & Hemmati‐Sadeghi, S. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3296 · Cited by 1 · see citing works
Book Review: The Doctrine of Continuous Voyage
Borchard, E. M. (1927) · bepress Legal Repository
Xiao, W. A. N. G., Shen, H., Yixin, W. A. N. G., Ma, H., & LIANG, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1086569/v1
Brague, J. C., & Seal, R. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.10.475638
Gendelman, H. E., Olson, K. E., Namminga, K. L., Lu, Y., Mostafa, M., Obaro, H., Santamaria, P. M., & Mosley, R. L. (2022) · Research Square · doi:10.21203/rs.3.rs-1957469/v1
Saving or Replacing Nerve Cells: Which Strategy is More Successful?
Klimaschewski, L. P. (2022) · Springer eBooks · doi:10.1007/978-3-662-66369-1_3
Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers
Schootemeijer, S., Coker, D., Shelton, J. F., Chanoff, E., Rowbotham, H. M., Darweesh, S. K. L., Bloem, B. R., Cannon, P., & de Vries, N. M. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105497
Neuroprotection induced by neurotrophic factors
Réus, G. Z., Manosso, L. M., Botelho, M. E. M., Arent, C. O., Pedro, L. C., & Quevedo, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00063-4
Brague, J. C., Sinha, G. P., Henry, D. A., Headrick, D. J., Hooks, B. M., Seal, R. P., & Seal, R. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596192
Nameni, F., Akbari, G., Hadavand, V., Entezari, H., Molaii, S., & Ghadami, N. (2024) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-146344
Skelton, H. M., Hyman, N., Fernandez, A. M., Acerbo, E., Scott, M., Berglund, K., Gutekunst, C., & Gross, R. E. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1796624
Buczek, A., Jakubczyk, P., Bilczewska, O., Janik, W., Handschuh, M., Helis, J., Widera, P., Banaś, A., Michalik, M., & Bigajski, H. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56588
Nameni, F., & Dehkordi, M. R. A. K. (2025) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2025.100206
Épidémiologie descriptive et étiologique
Elbaz, A., Artaud, F., Domenighetti, C., Hajji, M., Nguyen, T. T. H., Portugal, B., & Moisan, F. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78712-6.00002-6
Jacquot, P., Thom, J. M., Singh, M. F., & Hackett, D. A. (2025) · Translational Journal of the American College of Sports Medicine · doi:10.1249/tjx.0000000000000323
Current Strategies for Healthy Aging: The Interplay Between Nutrition, Metabolism, and Exercise
Matos, A., Tihon, C., Costa, C., & Domingues, C. (2025) · Cureus · doi:10.7759/cureus.96848
Anatomical, Physiological, Pathological, and Genetic Changes in Parkinson's Disease
Karimzadeh, M. H., Shirian, S., Heidary, P., & Moghadam, B. B. (2025) · The Neuroscience Journal of Shefaye Khatam · doi:10.61882/shefa.14.1.104
Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2024) · Figshare · doi:10.6084/m9.figshare.26590808
Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2024) · Figshare · doi:10.6084/m9.figshare.26590811
Hu, S., Yang, Y., & Li, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1836124
Moghadasi, M., Abdollahi, S., Edalatmanesh, M. A., Motl, R. W., Najafi, P., & Salehi, O. (2026) · Neurological Research · doi:10.1080/01616412.2026.2721323
Zhang, C., Zhang, X., Cao, L., Li, J., Zhang, Z., & Zang, W. (2026) · Bioengineering · doi:10.3390/bioengineering13091027
Therapeutic targeting of tauopathies: From druggable biology to precision intervention
Zhang, C., Ma, J., Wu, X., Wang, X., Huang, X., Zheng, H., & Zhao, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108432
Mesquita, I., Araújo, B., Soares-Guedes, C., Teixeira, C., Caridade-Silva, R., Summavielle, T., Pinto, L., Domingos, J., Godinho, C., & Teixeira, F. G. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119954
Bertasini, C., Haghighi, S. T., Bruno, M. G., Paio, F., Artusi, C. A., Brunelli, M., Schena, F. F., Venturelli, M., Moretti, U., Romanelli, M. G., et al. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1924016
- Authors
- Palasz, E., Niewiadomski, W., Gasiorowska, A., Wysocka, A., Stepniewska, A., & Niewiadomska, G.
- Affiliations
- Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
- Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL)
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2019-11-01
- Volume
- 10
- Pages
- 1143-1143
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC6838750
- OpenAlex
- W2983897971
- Cited by
- 95
- References
- 182
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 17 · 2023: 13 · 2022: 16 · 2021: 11 · 2020: 10 · 2017: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- TauRx Pharmaceuticals
- Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- Parkinson's disease, physical activity, neuroprotection, motor recovery, dopaminergic neurons, substantia nigra, neurotrophic factors, neurogenesis, Parkinson's disease model, exercise therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review